A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, 12-Week Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood P/266/2011, P267/2011, P268/2011

Trial Profile

A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, 12-Week Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood P/266/2011, P267/2011, P268/2011

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms PASCAL401
  • Sponsors Kowa
  • Most Recent Events

    • 28 Mar 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 20 Oct 2012 Planned End Date 25 Mar 2013 added as reported by EudraCT (Parent trial: EudraCT2011-004964-32).
    • 01 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top